Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Refractory, with Excess of Blasts × entinostat × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Urinary Bladder Neoplasms 2 Recurrence 2 Pancreatic Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Penile Neoplasms 1 Oropharyngeal Neoplasms 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Lymphoma 1 Head and Neck Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Breast Neoplasms, Male 1 Brain Neoplasms 1 Anus Neoplasms 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Cyclophosphamide 15 fludarabine phosphate 12 Whole-Body Irradiation 12 Mycophenolic Acid 12 fludarabine 11 Tacrolimus 8 Peripheral Blood Stem Cell Transplantation 8 Busulfan 8 Melphalan 7 Granulocyte Colony-Stimulating Factor 5 Cyclosporine 5 Azacitidine 5 Filgrastim 4 venetoclax 3 Cord Blood Stem Cell Transplantation 3 Biopsy 3 thymoglobulin 2 decitabine and cedazuridine drug combination 2 Vorinostat 2 Thiotepa 2 Specimen Handling 2 Sirolimus 2 Rituximab 2 Methotrexate 2 Hematopoietic Stem Cell Transplantation 2 Etoposide 2 Cyclosporins 2 Clofarabine 2 Bone Marrow Transplantation 2 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡